Biocon Academy has launched Syngene IBAB Certificate Programme in Artificial Intelligence in Life Sciences (SAILS) that has been developed in partnership with Syngene, a Biocon Group Company and the Institute of Bioinformatics and Applied Biotechnology (IBAB). This first-of-its-kind certificate programme reflects Biocon Academy’s commitment to advancing high-quality, industry-relevant education in India’s biotechnology sector.

SAILS is designed as a future-oriented, industry-aligned certification that integrates core disciplines such as Artificial Intelligence (AI), Data Science and Life Sciences to develop talent equipped for cutting-edge research, innovation and discovery. Admissions are open for the programme, and the first batch of classes will commence in Q1 FY2027.

The 16-week certificate programme is designed to equip graduates and postgraduates in computer science, information technology, pharmacy and life sciences disciplines (biotechnology, microbiology and biochemistry), with cutting-edge knowledge. The programme provides a strong foundation in applying AI to solve complex problems in the life sciences industry, with an emphasis on real-life problem-solving skills. The launch of the SAILS programme highlights Biocon Group’s broader vision of advancing scientific excellence and enabling the next generation of biotech professionals.

Bindu Ajit, Programme Dean, Biocon Academy, said, “At Biocon Academy, our mission has always been to prepare future-ready talent for the life sciences industry. The integration of Artificial Intelligence with biology is not just an emerging trend, it is rapidly becoming the backbone of modern scientific innovation. The SAILS programme has been designed with this vision in mind: to empower learners with the inter-disciplinary expertise needed to excel in AI-driven drug discovery, genomics and precision medicine. We are delighted to partner with Syngene and IBAB to bring this programme to life, and I am confident that SAILS graduates will lead the next wave of transformative breakthroughs in the biotech ecosystem.”

With the rapid adoption of AI-driven approaches in areas like drug development, diagnostics and molecular research, there is a growing need for skilled talent that can bridge computational sciences and biology. The SAILS programme aims to address this industry gap by equipping learners with practical and inter-disciplinary skills and hands-on exposure to emerging technologies.

Professor D Sundar, Director, IBAB, and Chair, Biocon, said, "IBAB has always believed in equipping students with deep scientific understanding supported by cutting-edge technological skills. The convergence of AI and life sciences is opening unprecedented opportunities, and the SAILS programme stands at the forefront of this transformation. Through this collaboration with Biocon Academy and Syngene, we aim to nurture professionals who can bridge computational intelligence with biological insight—individuals capable of solving complex scientific challenges using data, models and innovation. We are proud to support this unique programme and look forward to seeing its participants become leaders in the AI-driven biotech revolution."